Behavioural Sciences Unit, proudly supported by the Kids with Cancer Foundation
  • Home
  • About
    • Our approach
    • Our team >
      • Psychologists
  • Research
    • Ethics and Genetics
    • Mental Health
    • Health Behaviours
    • Family systems and relationships
    • Education and Cognition
  • Study with us
    • How to apply
    • Our supervisors
    • Positions vacant
  • News
    • Events
  • How to Help
  • Resources
    • Useful Links
    • Follow-Up Clinics
  • Contact Us
    • Contact Us
    • Directions
  • Blog

BSU Blog

Welcome to the BSU blog. Please check back regularly for new posts!

Blog archive

New paper: The hopes and challenges of precision medicine for children with cancer

24/2/2020

0 Comments

 
Children with high-risk cancers tend to have limited treatment options, with often devastating consequences. Precision medicine, which uses new technologies to better understand the causes of each child’s cancer and to test new treatment options, is offering new survival hope for children and their families.

As with any radical shift in medicine, challenges can emerge as healthcare professionals try to add new approaches into their practice. In this study, recently published in the Journal of Personalized Medicine, we wanted to better understand the challenges faced by doctors and scientists working on PRecISion Medicine for Children with Cancer (PRISM), an Australian precision medicine program for children with high-risk cancers (more information about the trial is available here: http://www.zerochildhoodcancer.org.au/page/4/about).

Key findings
In this study, we interviewed a broad group of doctors (including paediatric oncologists, pathologists and genetics professionals) and scientists (including laboratory scientists and bioinformaticians) working on PRISM.
 
Most professionals we interviewed were excited about the potential of precision medicine over the long-term, but were mindful of the importance of managing families’ expectations in the early stages of the trial. Key challenges for doctors, especially oncologists, included sharing genomic results with families. Doctors who did not specialise in cancer genetics told us that they felt unsure talking with families about results which might suggest that cancers ‘run in the family’. From our conversations with scientists, the overwhelming impression was that being part of such a ‘high-stakes’ trial made them feel new emotional pressures and experience new workload demands.  
 
We will use the evidence from this world-first study to inform our understanding of how best to support doctors and scientists striving for new treatment options for children with cancer.
     
This paper was led by Brittany McGill and can be accessed here at the Journal of Personalized Medicine: https://www.mdpi.com/2075-4426/10/1/9
0 Comments

    Archives

    September 2020
    August 2020
    July 2020
    May 2020
    April 2020
    March 2020
    February 2020
    December 2019
    November 2019
    September 2019
    August 2019
    July 2019
    June 2019
    March 2019
    February 2019
    January 2019
    October 2018
    September 2018
    August 2018
    July 2018
    May 2018
    April 2018
    March 2018
    November 2017
    October 2017
    September 2017
    April 2017
    March 2017
    January 2017
    October 2016
    September 2016
    August 2016
    July 2016
    June 2016
    May 2016
    April 2016
    March 2016
    February 2016
    January 2016
    December 2015
    November 2015
    October 2015
    September 2015
    August 2015
    June 2015
    May 2015

    Categories

    All

    RSS Feed

Photos used under Creative Commons from alant79, technotheory, laura dye